Columbia announces the Life Sciences Group has been renamed to Science + Technology to better reflect their focus on the construction and renovation of biotechnology, pharmaceutical R&D, manufacturing, chemical, battery, semiconductor, robotics, healthcare, medical device, and tech spaces.

“Columba’s Science + Technology Group is the natural evolution of our long-time work bringing science to life,” says Bill Olson, Vice President | Science + Technology. “Columbia’s technical facility design excellence and flexible and innovative problem-solving have long supported extraordinary results. As we expand our reach within this impactful arena, we look forward to accomplishing even more complex and inventive projects.”

The Columbia Science + Technology Group builds upon the firm’s comprehensive portfolio of laboratories, manufacturing facilities, cleanrooms, pilot plants, warehouses, bulk chemical plants, biological processing facilities, and other related sites. The Science + Technology Group utilizes sophisticated building information modeling tools to deliver a safe and efficient project, and its ambitious work is supported by Columbia’s in-house Energy Division, ensuring that projects are sustainable and energy-efficient. Columbia works within the guidelines of ASME, ASHRAE, API, ANSI, OSHA, EPA, cGMP, AAALAC, and FDA regulations.

“We have built a robust internal staff structure comprised of an impressive team of subject matter experts with a team-oriented focus to execute all our clients’ project goals,” says James Wrisley, Operations Director | Science + Technology.